Clinical Trials on Metastatic Breast Cancer in United Kingdom
Total 26604 results
-
EnhancedBio USA Inc.ZenopharmRecruitingMetastatic Breast Cancer | Locally Advanced Breast Cancer | HER2-Negative | Estrogen Receptor-PositiveUnited States, Korea, Republic of
-
Case Comprehensive Cancer CenterCompletedMetastatic Breast Cancer | Brain MetastasesUnited States
-
University of Alabama at BirminghamSusan G. Komen Breast Cancer Foundation; Daiichi Sankyo UK Ltd.; Triple Negative...CompletedBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Stage IV Breast CancerUnited States
-
Oncology Specialties, AlabamaTerminatedMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.; Corcept Therapeutics; Breast Cancer Research FoundationRecruitingMetastatic Breast CancerUnited States
-
AstraZenecaActive, not recruitingMetastatic Triple Negative Breast CancerUnited States, Belgium, Italy, Spain, United Kingdom, Canada, Czechia, Poland, France, Korea, Republic of, Germany, Taiwan, Portugal, Netherlands, Ireland
-
OncoMed Pharmaceuticals, Inc.CompletedMetastatic Breast CancerUnited States
-
Genentech, Inc.BioNTech SEActive, not recruitingMelanoma | Head and Neck Cancer | Colorectal Cancer | Non-Small Cell Lung Cancer | Bladder Cancer | Triple Negative Breast Cancer | Renal Cancer | Other Solid CancersUnited States, Belgium, Sweden, Germany, Canada, Spain, United Kingdom, Netherlands
-
GlaxoSmithKlineCompletedMetastatic Breast Cancer | Neoplasms, BreastUnited States
-
University of ManchesterManchester University NHS Foundation TrustCompleted
-
Dompé Farmaceutici S.p.APRA Health SciencesCompletedMetastatic Breast CancerUnited States, Spain, Belgium, Italy, France, Czechia, Poland
-
Polyphor Ltd.CompletedMetastatic Breast CancerSpain, United States
-
M.D. Anderson Cancer CenterWithdrawnAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Breast Carcinoma | Hormone Receptor Positive Breast Adenocarcinoma | Metastatic HER2 Negative Breast AdenocarcinomaUnited States
-
Daiichi SankyoAstraZenecaRecruitingMetastatic Cancer | Advanced CancerSpain, Korea, Republic of, Belgium, Italy, France, United States, Australia, Japan, Taiwan, United Kingdom
-
Merrimack PharmaceuticalsCompletedMetastatic Breast Cancer | Her2 Amplified Solid TumorsUnited States
-
OHSU Knight Cancer InstituteAstraZeneca; Oregon Health and Science UniversityRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast CarcinomaUnited States
-
Virginia Commonwealth UniversityEli Lilly and Company; BayerTerminatedBreast Cancer | Metastatic Breast Cancer | Recurrent Breast CancerUnited States
-
NewLink Genetics CorporationCompletedMetastatic Breast CancerUnited States, Poland
-
Verastem, Inc.TerminatedMetastatic Cancer | Non Hematologic CancersUnited States
-
Novartis PharmaceuticalsCompletedAdvanced or Metastatic Breast CancerSpain, United States
-
US Oncology ResearchNovartis PharmaceuticalsCompletedBreast Cancer | Metastatic Breast Cancer | Brain MetastasesUnited States
-
PrECOG, LLC.NovartisCompletedMetastatic Breast CancerUnited States
-
Steven J Isakoff, MD, PhDDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; AbbottActive, not recruitingBreast Cancer | Metastatic Breast Cancer | BRCA1 Gene Mutation | brca2 Gene MutationUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingStage IV Breast Cancer AJCC v6 and v7 | Metastatic Breast CarcinomaUnited States
-
US Oncology ResearchBristol-Myers SquibbCompleted
-
US Oncology ResearchOrtho Biotech, Inc.; Tibotec Pharmaceutical LimitedCompleted
-
SOLTI Breast Cancer Research GroupNovartis; Alliance Foundation Trials, LLC.RecruitingMetastatic Breast CancerUnited States, Spain, Portugal
-
National Cancer Institute (NCI)CompletedBreast Cancer | Metastatic CancerUnited States
-
US Oncology ResearchTranslational Drug Development; Life Technologies, Inc.CompletedMetastatic Breast Cancer | Triple Negative Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingHormone Receptor Positive Metastatic Breast CancerUnited States
-
DualityBio Inc.BioNTech SERecruitingMetastatic Breast CancerUnited States, China, France, Australia
-
Stemline Therapeutics, Inc.RecruitingBreast Cancer | Metastatic Breast CancerUnited States
-
Yuan YuanGateway for Cancer Research; Agenus Inc.RecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast CarcinomaUnited States
-
Angle plcCompletedHealthy Volunteers | Breast Cancer, MetastaticUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Not yet recruitingAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Breast CarcinomaUnited States
-
Genentech, Inc.Completed
-
Milton S. Hershey Medical CenterPenn State University; American Institute for Cancer ResearchCompleted
-
Pamela MunsterQuantumLeap Healthcare CollaborativeTerminatedTriple Negative Metastatic Breast Cancer | BRCA-mutated Solid TumorUnited States
-
Daiichi Sankyo Co., Ltd.Daiichi Sankyo, Inc.CompletedMetastatic Breast CancerUnited States, Japan
-
Imperial College Healthcare NHS TrustImperial College LondonTerminatedBreast Cancer | Breast DiseaseUnited Kingdom
-
Zedsen LimitedImperial College Healthcare NHS TrustRecruitingBreast Cancer | Benign Breast DiseaseUnited Kingdom
-
US Oncology ResearchBristol-Myers Squibb; PfizerActive, not recruiting
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI); United States Department of DefenseCompleted
-
Novartis PharmaceuticalsTerminatedAdvanced or Metastatic ER+ Breast CancerUnited States, France, Germany, Singapore, Italy, Japan, Belgium
-
University of California, San FranciscoNational Cancer Institute (NCI)CompletedBreast Cancer | Metastatic CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMetastatic Triple-Negative Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Breast AdenocarcinomaUnited States
-
IpsenTerminatedSmall Cell Lung Cancer and Breast CancerUnited States, Austria, France, Switzerland, Germany, United Kingdom, Belgium
-
National Cancer Institute (NCI)TerminatedAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Inflammatory CarcinomaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); AmgenTerminatedStage IV Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Breast Carcinoma Metastatic in the Bone | Circulating Tumor Cell CountUnited States
-
Elevation OncologyTerminatedMetastatic Breast CancerGermany, Spain, United States, Austria, Belgium, Canada